Package Leaflet: Information for the User
Pritor 80 mg Tablets
telmisartan
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Pritor belongs to a class of medicines known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body that causes your blood vessels to narrow, thus increasing your blood pressure. Pritor blocks the effect of angiotensin II, so that your blood vessels relax and your blood pressure is reduced.
Pritor is used totreat essential hypertension (high blood pressure) in adults. "Essential" means that the high blood pressure is not caused by any other condition.
High blood pressure, if left untreated, can damage blood vessels in various organs, which can lead, in some cases, to heart attacks, heart failure, or kidney failure, strokes, or blindness. Usually, there are no symptoms of high blood pressure before damage occurs. Therefore, it is important to regularly measure your blood pressure to check if it is within the normal range.
Pritor is also used toreduce cardiovascular events (e.g., heart attacks or strokes) in adults at risk because their blood supply to the heart or legs is reduced or blocked, or they have had a stroke or have a high risk of developing diabetes. Your doctor will inform you if you have a high risk of developing these events.
Do not take Pritor
If any of the above applies to you, tell your doctor or pharmacist before taking Pritor.
Warnings and precautions
Tell your doctor before starting treatment with Pritor if you are suffering from or have ever suffered from any of the following conditions or diseases:
Tell your doctor before starting treatment with Pritor:
Your doctor may check your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals. See also the information under the heading "Do not take Pritor".
If you are pregnant, think you may be pregnant, or are planning to become pregnant, tell your doctor. Pritor is not recommended during the first three months of pregnancy and should not be taken after the third month of pregnancy as it may cause serious harm to your baby, see section Pregnancy.
In case of surgery or anesthesia, inform your doctor that you are taking Pritor.
Pritor may be less effective in lowering blood pressure in black patients.
Children and adolescents
Pritor is not recommended for use in children and adolescents under 18 years.
Other medicines and Pritor
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Your doctor may need to change the dose of these medicines or take other precautions. In some cases, you may need to stop taking one of the medicines. This is especially applicable to the following medicines when taken with Pritor:
The effect of Pritor may be reduced when you use NSAIDs (non-steroidal anti-inflammatory drugs, e.g., aspirin or ibuprofen) or corticosteroids.
Pritor may increase the blood pressure-lowering effect of other medicines used to treat high blood pressure or medicines that may potentially lower blood pressure (e.g., baclofen, amifostine).
Additionally, the reduction in blood pressure may be enhanced by alcohol, barbiturates, narcotics, or antidepressants. You may notice this effect as dizziness when standing up. You should consult your doctor if you need to adjust the dose of your other medicines while taking Pritor.
Pregnancy and breastfeeding
Pregnancy
Tell your doctor if you are pregnant, think you may be pregnant, or are planning to become pregnant. Your doctor will normally advise you to stop taking Pritor before you become pregnant or as soon as you know you are pregnant, and will advise you to take another medicine to treat your high blood pressure. Pritor is not recommended during the first three months of pregnancy and should not be taken after the third month of pregnancy as it may cause serious harm to your baby.
Breastfeeding
Tell your doctor if you are about to start or are already breastfeeding. It is not recommended to take Pritor while breastfeeding. Your doctor may decide to give you a different treatment that is more suitable if you want to breastfeed, especially if you are breastfeeding a newborn or premature baby.
Driving and using machines
Some people feel dizzy or tired when taking Pritor. If you feel dizzy or tired, do not drive or use machines.
Pritor contains sorbitol
This medicine contains 337.28 mg of sorbitol in each tablet. Sorbitol is a source of fructose. If your doctor has told you that you have an intolerance to some sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder, in which the patient cannot break down fructose, consult your doctor before taking this medicine.
Pritor contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one tablet per day. Try to take the tablet at the same time each day. You can take Pritor with or without food. The tablets should be swallowed with a little water or other non-alcoholic drink. It is important that you take Pritor every day until your doctor tells you to stop. If you feel that the effect of Pritor is too strong or too weak, talk to your doctor or pharmacist.
For the treatment of high blood pressure, the usual dose of Pritor for most patients is one 40 mg tablet once a day, to control blood pressure over 24 hours. However, your doctor may sometimes recommend a lower dose of 20 mg or a higher dose of 80 mg. Pritor can also be used in combination with diuretics such as hydrochlorothiazide, which has been shown to have an additive blood pressure-lowering effect with Pritor.
For the reduction of cardiovascular events, the usual daily dose of Pritor is one 80 mg tablet. At the start of treatment with Pritor 80 mg, blood pressure should be monitored.
If your liver is not working properly, the usual dose should not exceed 40 mg once a day.
If you take more Pritor than you should
If you accidentally take too many tablets, contact your doctor, pharmacist, or the nearest hospital emergency department immediately.
If you forget to take Pritor
If you forget to take a dose, do not worry. Take it as soon as you remember and then continue as before. If you do not take your tablet one day, take your normal dose the next day. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious and require immediate medical attention
If you experience any of the following symptoms, you should see your doctor immediately:
Sepsis* (often called "blood infection", a serious infection that involves an inflammatory reaction of the whole body), rapid swelling of the skin and mucous membranes (angioedema); these side effects are rare (may affect up to 1 in 1,000 people) but are extremely serious and patients should stop taking the medicine and see their doctor immediately. If these side effects are not treated, they can be fatal.
Possible side effects of Pritor
Common side effects (may affect up to 1 in 10 people)
Low blood pressure (hypotension) in users treated for cardiovascular event reduction.
Uncommon side effects (may affect up to 1 in 100 people)
Urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), decreased red blood cells (anemia), high levels of potassium, difficulty falling asleep (insomnia), feeling sad (depression), fainting (syncope), feeling of losing balance (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness when standing up (orthostatic hypotension), difficulty breathing, cough, abdominal pain, diarrhea, abdominal discomfort, abdominal distension, vomiting, itching, increased sweating, drug rash (reaction of the skin to medicines), back pain, muscle cramps, muscle pain (myalgia), kidney problems including acute kidney failure, chest pain, symptoms of weakness, and high levels of creatinine in the blood.
Rare side effects (may affect up to 1 in 1,000 people)
Sepsis* (often called "blood infection", a serious infection that involves an inflammatory reaction of the whole body and can cause death), increased certain white blood cells (eosinophilia), low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, drowsiness, vision disturbance, increased heart rate (tachycardia), dry mouth, stomach upset, taste disturbance (dysgeusia), abnormal liver function (Japanese patients show a higher tendency to experience this side effect), sudden swelling of the skin and mucous membranes that can cause death (angioedema including fatal outcome), eczema (a skin disorder), redness of the skin, hives (urticaria), severe drug rash, joint pain (arthralgia), pain in the limbs, pain in the tendons, pseudo-influenza, decrease in hemoglobin (a blood protein), increased blood levels of uric acid, increased liver enzymes or creatine phosphokinase in the blood.
Very rare side effects (may affect up to 1 in 10,000 people)
Progressive scarring of lung tissue (interstitial lung disease) **.
** Cases of progressive scarring of lung tissue have been reported during treatment with telmisartan. However, it is not known whether telmisartan was the cause.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions. Store in the original package to protect from moisture. Take your Pritor tablet out of the blister pack just before you take it.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Pritor Composition
The active ingredient is telmisartan. Each tablet contains 80 mg of telmisartan.
The other components are povidone (K25), meglumine, sodium hydroxide, sorbitol (E420), and magnesium stearate.
Product Appearance and Package Contents
Pritor 80 mg are white, oblong tablets with the code “52H” engraved.
Pritor is available in blister packs containing 14, 28, 30, 56, 90, 98, or 280 tablets, or in single-dose blisters containing 28 x 1 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder.
Belgium / Belgique / Belgien Bayer SA-NV Tel: +32-(0)2-535 63 11 | Lithuania UAB Bayer Tel: +370 52 33 68 68 |
Luxembourg / Luxemburg Bayer SA-NV Tel: +32-(0)2-535 63 11 | |
Czech Republic Bayer s.r.o. Tel: +420 266 101 111 | Hungary Bayer Hungária Kft. Tel: +36-14 87-41 00 |
Denmark Bayer A/S Tel: +45-45 23 50 00 | Malta Alfred Gera and Sons Ltd. Tel: +356-21 44 62 05 |
Germany Bayer Vital GmbH Tel: +49-(0)214-30 513 48 | Netherlands Bayer B.V. Tel: +31-(0)297-28 06 66 |
Estonia Bayer OÜ Tel: +372 655 85 65 | Norway Bayer AS Tel: +47 23 13 05 00 |
Greece Bayer Ελλάς ΑΒΕΕ Tel: +30 210 618 75 00 | Austria Bayer Austria Ges. m. b. H. Tel: +43-(0)1-711 46-0 |
Spain Bayer Hispania S.L. Tel: +34-93-495 65 00 | Poland Bayer Sp. z o.o. Tel: +48-22-572 35 00 |
France Bayer HealthCare Tel (Green Number): +33-(0)800 87 54 54 | Portugal Bayer Portugal Lda Tel: +351-21-416 42 00 |
Croatia Bayer d.o.o. Tel: +385-(0)1-6599 900 | Romania SC Bayer SRL Tel: +40 21 528 59 00 |
Ireland Bayer Limited Tel: +353 1 299 93 13 | Slovenia Bayer d. o. o. Tel: +386-1-58 14 400 |
Iceland Icepharma hf. Tel: +354 540 8000 | Slovak Republic Bayer, spol. s r.o. Tel: +421 2 59 21 31 11 |
Italy Bayer S.p.A. Tel: +39-02-397 81 | Finland Bayer Oy Tel: +358-20 785 21 |
Cyprus NOVAGEM Limited Tel: +357 22 48 38 58 | Sweden Bayer AB Tel: +46-(0)8-580 223 00 |
Latvia SIA Bayer Tel: +371 67 84 55 63 | United Kingdom Bayer plc Tel: +44 (0) 118 206 3000 |
Date of the last revision of this leaflet: {MM/AAAA}.
Other sources of information
Detailed information about this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.